While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) came out with quarterly earnings of $4.81 per share, beating the Zacks Consensus Estimate of $4.54 per share. This compares to earnings of $3.49 per share a year ago.
Globe Life offers a mix of life and health insurance products, with growth recently centered around health insurance. Q2 2025 results were solid on both a GAAP and operating income basis, prompting the company to increase its full-year guidance. Globe Life's common stock remains attractively valued, with the shares trading at just 9.3x its 2026 consensus operating earnings.
| Insurance - Life Industry | Financial Services Sector | Frank Martin Svoboda CEO | XSTU Exchange | US37959E1029 ISIN |
| US Country | 3,732 Employees | 5 Jan 2026 Last Dividend | 2 Jul 2014 Last Split | 30 Dec 1987 IPO Date |
Globe Life Inc. engages in providing a diverse range of life and supplemental health insurance products along with annuities aimed predominantly at lower middle- and middle-income families across the United States. This ambit is structured into four operational segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Initially known as Torchmark Corporation, it underwent a name change to Globe Life Inc. in August 2019, signaling a new era under a brand that reflects its comprehensive offerings in the life insurance market. Founded in 1900, the company has its headquarters located in McKinney, Texas, marking over a century of service in the insurance sector. Globe Life Inc. leverages a variety of channels to market and sell its products, including direct to consumer campaigns, exclusive agencies, and a network of independent agents, ensuring a widespread reach to its target demographic.